C12Y 301/01025
1,4-lactonase
Official title: 1,4-Lactonase (3.1.1.25)
C12Y301/01025 (1,4-lactonase) appears on 11 US grants and 18 published applications in this corpus.
Search patents in C12Y- Granted patents
- 11
- Published applications
- 18
- Assignees
- 15
- Inventors
- 46
- Latest grant
- 7 Jan 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2011 | 0 | 1 |
| 2012 | 0 | 1 |
| 2013 | 0 | 2 |
| 2014 | 0 | 1 |
| 2015 | 0 | 4 |
| 2016 | 3 | 1 |
| 2017 | 3 | 3 |
| 2018 | 2 | 0 |
| 2019 | 2 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 1 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 1 | 2 |
By publication year.
Recent patents
- Method for resolving optical isomer by using supercritical fluid extraction technology7 Jan 2025US 12,188,066 B2Guang An Mojia Biotechnology Co., Ltd.
- Cell lines9 Apr 2019US 10,253,345 B2MedImmune, LLC
- Amino acid derivatives26 Feb 2019US 10,214,761 B2MedImmune, LLC
- Lactonase enzymes and methods of using same25 Sep 2018US 10,081,800 B1Fornia BioSolutions, Inc.
- Mycotoxin-reducing composition27 Feb 2018US 9,901,108 B2
- Method for producing 2,4-dihydroxy butyrate or l-threonine using a microbial metabolic pathway6 Nov 2025US 2025/0340912 A1Technische UniversitäT Dresden
- Biochemical pathway for the production of tulipalin a via itaconic acid9 Oct 2025US 2025/0313871 A1BASF SE
- Compositions comprising aromatic dipeptides-based structures encapsulating an esterase and uses thereof20 Jul 2023US 2023/0225332 A1Migal Galilee Research Institute Ltd.
- Method for resolving optical isomer by using supercritical fluid extraction technology23 Jun 2022US 2022/0195471 A1Guang An Mojia Biotechnology Co., Ltd.
- Whole-cell biocatalysis method for producing alpha, omega-dicarboxylic acids and use thereof21 Oct 2021US 2021/0324426 A1Hubei University
Most cited
By later US patents
- Amino acid derivatives23US 9,670,521 B2MedImmune, LLC · 2017
- Mycotoxin-reducing composition7US 9,901,108 B22018
- Methods of producing carboxylic acids5US 9,334,508 B2Invista North America S A R L · 2016
- Cell lines2US 9,732,367 B2MedImmune, LLC · 2017
- Biocatalytic methods to convert cyclohexane oxidation process waste streams to useful products2US 9,783,833 B2Invista North America S A R L · 2017